| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,576,000 | 1,640,000 | 2,766,000 | 2,774,000 | | Cost of Revenue | 582,000 | 710,000 | 1,789,000 | 3,293,000 | | | Gross Profit | 994,000 | 930,000 | 977,000 | (519,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 499,000 | 489,000 | 526,000 | (990,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 208,000 | 188,000 | 166,000 | 168,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 287,000 | 253,000 | 285,000 | 303,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26,000 | 27,000 | (8,000) | (46,000) | | Earnings Before Interest And Taxes | 310,000 | 291,000 | 277,000 | 308,000 | | Interest Expense | 158,000 | 162,000 | 162,000 | 156,000 | | Income Before Tax | 152,000 | 129,000 | 115,000 | 152,000 | | Income Tax Expense | 38,000 | 43,000 | 48,000 | 65,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 114,000 | 86,000 | 67,000 | 87,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 114,000 | 86,000 | 67,000 | 87,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $114,000 | $86,000 | $67,000 | $87,000 |
|
2.03% Nasdaq 
Income Statement
